https://vax-trust.eu/wp-content/uploads/2021/12/consortium_meeting.jpg
400
500
halinoja
https://vax-trust.eu/wp-content/uploads/2021/11/vax-trust_color.png
halinoja2021-12-20 14:24:182022-02-07 10:35:00Consortium meeting in Finland
https://vax-trust.eu/wp-content/uploads/2021/12/consortium_meeting.jpg
400
500
halinoja
https://vax-trust.eu/wp-content/uploads/2021/11/vax-trust_color.png
halinoja2021-12-20 14:24:182022-02-07 10:35:00Consortium meeting in Finland
https://vax-trust.eu/wp-content/uploads/2021/11/3_microphone.jpg
400
500
pm
https://vax-trust.eu/wp-content/uploads/2021/11/vax-trust_color.png
pm2021-10-13 15:27:512022-01-13 13:47:06Euractiv.pl interviewed our PI
https://vax-trust.eu/wp-content/uploads/2021/11/2_vuolanto.jpg
400
500
pm
https://vax-trust.eu/wp-content/uploads/2021/11/vax-trust_color.png
pm2021-08-05 12:41:492021-11-30 14:12:50Our PI’s interview on the International Hospital magazineAIM OF VAX-TRUST
We study vaccine hesitancy as a broad societal phenomenon with the primary aim of improving the experience of healthcare professionals and patients in encountering the topic of vaccination.
FUNDING
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under Grant Agreement No 965280.


